• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX25015UX
Device Problem Defective Component (2292)
Patient Problem Intimal Dissection (1333)
Event Date 08/06/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
A resolute onyx rx drug eluting stent was used to treat a moderate tortuosity, severely calcified lesion in the lad.The lesion was described as a total occlusion, non chronic, stemi at 100%.There was severe calcification throughout entire vasculature, chronically totalled rca.The device was inspected with no issues noted.Negative prep was performed with no issues.The lesion was pre dilated with a 2.5mm non-medtronic balloon.The device did not pass through a previously deployed stent.Resistance was encountered however excessive force was not used during delivery.With the assistance of a guide liner, stent was deployed across the lesion and dilated to nominal pressure (12 atm).It was reported that the stent appeared larger than expected.It was reported that a distal edge dissection was observed.The dissection was treated with a subsequent onyx stent (2.25 x 12mm) which was inflated to 10 atm.It was reported that there was attempt made at ivus but they were unable to get the ivus catheter past the stent.A second in -deflator was used to expand both the 2.5mm onyx stent delivery system and the 2.5mm pre dilated non medtronic balloon to compare the sizes of the two devices outside the body.It was observed that the onyx stent delivery balloon looked to be larger than the non -medtronic pre-dilated balloon.Post procedure quantitative coronary angiography was carried out to confirm the stent size.The measurements indicated a mean of 2.95 mm on the onyx balloon.Onyx compliance chart indicates a stent size of 2.55 mm at 12 atms (nominal).
 
Manufacturer Narrative
Device evaluation summary: a resolute onyx 2.5mm*15mm delivery system, a non-medtronic 2.5mm*15mm poba device and two non-medtronic inflation devices received for analysis.The pressure of the inflation devices received were verified with a calibrated pressure gauge and confirmed to be reading correctly when pressurised to 12 atm.The resolute onyx balloon was inflated to nominal pressure of 12 atm using an inhouse inflation device with no issues noted.The od measurements of the balloon were recorded using a snap gauge and confirmed to be within manufacturing specifications.The balloon was rotated 90° and measured again and found to be within specification.The resolute onyx balloon was then inflated to nominal pressure of 12 atm using the one of the inflation devices that was received for analysis, with no issues noted.The od measurements were recorded again using a snap gauge and confirmed to be within manufacturing specifications.The balloon was rotated 90° and measured again and found to be within specification.The resolute onyx balloon was then inflated to nominal pressure of 12 atm using the remaining inflation device that was received for analysis, with no issues noted.The od measurements were recorded again using a snap gauge and confirmed to be within manufacturing specifications.The balloon was rotated 90° and measured again and found to be within specification.The non-medtronic device was inflated in order to capture image of the two devices.Image review:images confirm the presence of a cto in the lad that was resolved with ballooning and stenting with two (2) stents.The dimensional measurements of the proximal stent was shown in the images as measuring 2.58mm.It was not possible to confirm or deny this measurement from the images as it was not possible to accurately measure the images on the screen.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8868513
MDR Text Key153523247
Report Number9612164-2019-03245
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier00643169556805
UDI-Public00643169556805
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/16/2020
Device Catalogue NumberRONYX25015UX
Device Lot Number0009284403
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/12/2019
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/06/2019
Initial Date FDA Received08/07/2019
Supplement Dates Manufacturer Received09/16/2019
Supplement Dates FDA Received10/14/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/17/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-